サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566823

血管形成術用バルーン市場：タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年

Angioplasty Balloons Market By Type , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.69円
血管形成術用バルーン市場：タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血管形成術用バルーン市場は、2023年に26億米ドルと評価され、2024～2033年にかけてCAGR 3.4%で成長し、2033年には36億米ドルに達すると予測されています。

血管形成術用バルーンは、低侵襲の血管内装置であり、閉塞した血管や狭窄した血管を開くために使用されます。この装置によって適切な血流が回復し、冠動脈疾患、心臓発作、その他の心疾患の症状が緩和されます。この処置は一般的に開心術よりも安価であり、多くの患者にとって費用対効果の高い選択肢となっています。

世界の血管形成術用バルーン市場の成長を牽引しているのは、心血管疾患の憂慮すべき有病率の増加です。世界心臓連盟によると、心血管系疾患は他のどの原因よりも世界の死亡原因の第一位です。毎年約2,050万人が心血管疾患で死亡しています。このうち85％は冠動脈性心疾患（心臓発作など）と脳血管疾患（脳卒中など）によるものです。さらに、高齢者人口の増加が市場の成長に大きく寄与しています。これは、高齢者は心疾患に非常にかかりやすいという事実に起因しています。スペイン心臓学会の公式出版物であるRevista Espanola de Cardiologiaが発表した論文によると、冠動脈性心疾患は65歳以上の成人の81％の死亡原因となっています。さらに、血管形成術のような低侵襲手術は、回復が早く入院期間も短縮できるため、患者や医療プロバイダーの間で選好が高まっており、市場の成長を促進しています。しかし、血管形成術のコストが高く、動脈解離や再狭窄など血管形成術に伴う合併症が市場成長の妨げとなっています。一方、バルーンのデザイン、材料、画像技術の継続的な改善により、血管形成術の有効性と安全性が向上するため、予測期間中に市場拡大の好機が訪れると期待されます。

血管形成術用バルーンの世界市場は、タイプ、用途、エンドユーザー、地域に区分されます。タイプ別では、通常バルーン、薬剤溶出バルーン、カッティングバルーン、スコアリングバルーンに分類されます。用途別では、末梢と冠動脈に二分されます。エンドユーザー別では、ASC、病院、カテーテルラボに分類されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されています。

主要調査結果

タイプ別では、通常バルーンセグメントが2023年の主要収益源でした。

用途別では、冠動脈セグメントが血管形成術用バルーン市場で2023年に最大のシェアを占めました。

エンドユーザー別では、ASCsセグメントが2023年の主要株主でした。

地域別では、北米が2023年に最も高い収益を上げ、予測期間中に市場を独占すると予測されています。

本レポートのカスタマイズが可能です。

  • 顧客の関心に応じた企業プロファイルの追加

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 血管形成術用バルーン市場：タイプ別

  • 市場概要
  • 通常バルーン
  • 薬剤溶出バルーン
  • カッティングバルーン
  • スコアリングバルーン

第5章 血管形成術用バルーン市場：用途別

  • 市場概要
  • 末梢
  • 冠動脈

第6章 血管形成術用バルーン市場：エンドユーザー別

  • 市場概要
  • 造血幹細胞
  • 病院
  • カテーテルラボ

第7章 血管形成術用バルーン市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の血管形成術用バルーン市場
    • カナダの血管形成術用バルーン市場
    • メキシコの血管形成術用バルーン市場
  • 欧州
    • 主要市場動向と機会
    • フランスの血管形成術用バルーン市場
    • ドイツの血管形成術用バルーン市場
    • イタリアの血管形成術用バルーン市場
    • スペインの血管形成術用バルーン市場
    • 英国の血管形成術用バルーン市場
    • その他の欧州の血管形成術用バルーンの市場
  • アジア太平洋
    • 主要市場動向と機会
    • 中国の血管形成術用バルーン市場
    • 日本の血管形成術用バルーン市場
    • インドの血管形成術用バルーン市場
    • 韓国の血管形成術用バルーン市場
    • オーストラリアの血管形成術用バルーン市場
    • その他のアジア太平洋の血管形成術用バルーンの市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの血管形成術用バルーン市場
    • 南アフリカの共和国の血管形成術用バルーン市場
    • サウジアラビアの血管形成術用バルーン市場
    • その他のラテンアメリカ・中東・アフリカの血管形成術用バルーン市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE And Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health, Inc
  • MEDTRONIC PLC.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • THE SPECTRANETICS CORPORATION
目次
Product Code: A38595

The angioplasty balloons market was valued at $2.6 billion in 2023, and is projected to reach $3.6 billion by 2033, growing at a CAGR of 3.4% from 2024 to 2033.

Angioplasty balloon is a minimally invasive endovascular device is used to open up blocked or narrowed blood vessels. This device enables to restore proper blood flow, alleviating the symptoms of coronary artery disease, heart attacks, and other cardiac diseases. The procedure is generally less expensive than open heart surgery, making it a cost-effective option for many patients.

The growth of the global angioplasty balloons market is driven by alarming increase in prevalence of cardiovascular diseases. According to the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared to any other cause. Approximately 20.5 million die every year due to cardiovascular diseases. Of these deaths, 85% are due to coronary heart diseases (e.g., heart attacks) and cerebrovascular diseases (e.g., strokes). Moreover, increase in geriatric population significantly contributes toward the growth of the market. This is attributed to the fact that aged individuals are highly susceptible to cardiac diseases. As per the article published by the Revista Espanola de Cardiologia-the official publication of the Spanish Society of Cardiology-coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in preference for minimally invasive procedures among patients and healthcare providers like angioplasty due to quicker recovery times and reduced hospital stays foster the growth of the market. However, high cost of angioplasty and complications associated with angioplasty, such as arterial dissection or restenosis hamper the market growth. On the contrary, continuous improvements in balloon design, materials, and imaging technologies will enhance the efficacy and safety of angioplasty procedures, which are expected to offer remunerative opportunities for the expansion of the market during the forecast period.

The global angioplasty balloons market is segmented into type, application, end user, and region. On the basis of type, the market is classified into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. By application, it is bifurcated into peripheral and coronary. Depending on end user, it is segregated into ASCs, hospitals, and Cath labs. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the normal balloon segment was the major revenue generator in 2023.

By application, the coronary segment accounted for the largest share in 2023 in angioplasty balloons market.

Depending on end user, the ASCs segment held the was the key shareholder in 2023.

Region wise, North America generated the highest revenue in 2023 and is expected to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global angioplasty balloons market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc, MEDTRONIC PLC., MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Type

  • Normal Balloons
  • Drug Eluting Balloons
  • Cutting Balloons
  • Scoring Balloons

By Application

  • Peripheral
  • Coronary

By End User

  • ASCs
  • Hospitals
  • Cath Labs

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • C. R. Bard, Inc.
    • Cardinal Health, Inc
    • MEDTRONIC PLC.
    • MicroPort Scientific Corporation
    • Terumo Corporation
    • THE SPECTRANETICS CORPORATION

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ANGIOPLASTY BALLOONS MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Normal Balloons
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Drug Eluting Balloons
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Cutting Balloons
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Scoring Balloons
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Peripheral
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Coronary
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: ANGIOPLASTY BALLOONS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. ASCs
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Hospitals
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Cath Labs
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ANGIOPLASTY BALLOONS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Angioplasty Balloons Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Angioplasty Balloons Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Angioplasty Balloons Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Angioplasty Balloons Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Angioplasty Balloons Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Angioplasty Balloons Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Angioplasty Balloons Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Angioplasty Balloons Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Angioplasty Balloons Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Angioplasty Balloons Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Angioplasty Balloons Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Angioplasty Balloons Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Angioplasty Balloons Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Angioplasty Balloons Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Angioplasty Balloons Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Angioplasty Balloons Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Angioplasty Balloons Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Angioplasty Balloons Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Angioplasty Balloons Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. B. Braun Melsungen AG
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Biotronik SE And Co. KG
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Boston Scientific Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. C. R. Bard, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Cardinal Health, Inc
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. MEDTRONIC PLC.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. MicroPort Scientific Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Terumo Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. THE SPECTRANETICS CORPORATION
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments